TWiV 686: COVID-19 clinical update #38 with Dr. Daniel Griffin
Daniel Griffin provides his weekly clinical report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron\u2019s monoclonal antibody and more.
Hosts:\xa0Daniel Griffin and Vincent RacanielloSubscribe (free):\xa0iTunes,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- WHO Solidarity trial for Remdesivir and other drugs (medRxiv)
- EUA for Baricitinib (FDA)
- EUA for Casirivimab and Imdevimab (FDA)
- RCT: No benefit of convalescent plasma (NEJM)
- Letters read on TWiV 686
- Timestamps by Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv